1.Etiology and Pathogenesis, Syndrome Differentiation and Treatment, and Medication Rules of Diabetic Kidney Disease
Fengfeng ZHANG ; Qianwen YANG ; Yexin CHEN ; Yingchao WANG ; Zongjiang ZHAO
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(6):246-253
Diabetic kidney disease (DKD) is one of the most common microvascular complications of diabetes. Traditional Chinese medicine (TCM) plays a unique role in improving clinical symptoms, reducing proteinuria, and delaying the initiation of dialysis. Over time, scholars have held diverse views on the etiology, pathogenesis, and treatment strategies of DKD. This paper systematically reviews the etiology and pathogenesis, syndrome differentiation and treatment, and medication rules of DKD, aiming to provide a reference for clinical practice. Regarding etiology, DKD is closely related to insufficient innate endowment, improper diet, emotional disorders, overexertion, and prolonged diabetes. Its pathogenesis evolves dynamically. Specifically, early stage is characterized by Yin deficiency with dryness-heat and subtle discharge. Middle stage involves both Qi and Yin deficiency with dampness and blood stasis. Late stage presents Yin and Yang deficiency with intrinsic turbidity toxins. Blood stasis and sugar toxicity are the core pathological factors, persisting throughout the disease course and accelerating renal collateral damage and fibrosis. In terms of diagnosis and treatment, contemporary scholars advocate stage-specific treatment, emphasize the integration of prevention and therapy, recommend whole-course management, and support comprehensive TCM and Western medicine approaches. Analysis of medication rules shows that treatment consistently addresses the core principle of deficiency at the root and excess at the surface, strengthens the body while dispelling pathogenic factors, emphasizes promoting blood circulation and removing blood stasis, consolidates the kidney and astringes essence, clears Fu-organs and eliminates turbidity and toxins, invigorates the spleen, replenishes Qi, protects the stomach, and advocates treatment based on pathogenic wind. Further refinement of the academic thoughts of classical TCM masters and research into innovative pathogenesis theories and clinically effective prescriptions are needed to enhance TCM's ability to prevent and treat major clinical diseases, including DKD.
2.Digital biopsy for liver diseases: A review of technological advances and application prospects
Yang ZHOU ; Zhenwei CHEN ; Hanying SHI ; Kongying LIN ; Yingchao WANG ; Yongyi ZENG
Journal of Clinical Hepatology 2025;41(11):2207-2212
Digital biopsy for liver diseases is characterized by the deep integration of artificial intelligence (AI) technologies and large-scale liver disease data, through which intelligent analytics are applied to support clinical decision-making and full-cycle management. This article reviews the AI technical framework based on standardized data governance and centered on multimodal large medical models, covering the application of natural language processing, knowledge map, generative AI, and large language models in the establishment of databases for specialty diseases, diagnosis, prognosis prediction, treatment, and automated medical documentation. This article also discusses the application prospects of this framework in medical education, scientific research, and healthcare management. Although this technique shows broad application potential, it still faces challenges in areas such as multi-center data integration, model interpretability, ethics, and data security. In the future, a smart ecosystem with closed-loop optimization and human-AI collaboration should be established to promote the comprehensive implementation of digital biopsy in the whole process of medicine, education, research, and management, thereby providing help for the precise prevention and control and holistic health management of liver diseases.
3.Establishment of Human Luminal Breast Cancer Stem Cell Model and the Therapeutic Effects of Astragaloside Ⅳ
Liushan CHEN ; Huachao LI ; Yingchao WU ; Yuqi LIANG ; Peng WU ; Congwen YANG ; Junfeng HUANG ; Jieting CHEN ; Zhili ZENG ; Chen FANG ; Qian ZUO ; Qianjun CHEN
Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(9):2295-2304
Objective To establish a human luminal breast cancer stem cell(BCSC)model and investigate the inhibitory effects of astragaloside Ⅳ(AS-Ⅳ)on BCSC growth.Methods MCF-7 breast cancer cells were cultured in stem cell-specific medium to induce BCSC formation.The BCSCs were then divided into a blank control group and an AS-Ⅳ treatment group,both groups were given PBS or AS-Ⅳ treatment.Morphological changes were observed after intervention.The therapeutic efficacy of AS-Ⅳ was evaluated using 3D spheroid formation and cell viability assays.Transcriptomic profiling and gene expression analysis were performed to elucidate the underlying mechanisms.Results Compared with the MCF7 breast cancer cells,MCF7 breast cancer stem cell mammospheres exhibited accelerated growth(P<0.01)and significantly increased expression of the stemness marker ALDH1A1(P<0.01).Further comparison with the blank control group revealed that astragaloside Ⅳ(AS-Ⅳ)treatment significantly inhibited MCF7 breast cancer stem cell proliferation(P<0.001)and slowed mammosphere growth(P<0.01).Transcriptomic analysis demonstrated that differentially expressed genes(DEGs)induced by stem cell modeling and AS-Ⅳ intervention were enriched in the cellular senescence signaling pathway.AS-Ⅳ intervention substantially increased the number of SA-β-gal-positive cells(P<0.01).RT-PCR analysis confirmed that AS-Ⅳsignificantly upregulated mRNA expression of IL-1α(P<0.01),P21(P<0.001),and P53(P<0.05)in MCF7 breast cancer stem cells.Conclusion Astragaloside Ⅳ suppresses the growth of human luminal breast cancer stem cells by inducing cellular senescence.
4.Preliminary Discussion on the Treatment of Hidden Penis with Brisson Technique Combined with Precise Measurement Scheme
Bin YANG ; Caixia LIU ; Na GUO ; Haoyang GAO ; Yi WANG ; Nan LI ; Haitao CHEN ; Yingchao LI
Journal of Clinical Surgery 2025;33(5):470-473
Objective To explore the clinical effect of using the Brisson technique combined with a precise measurement scheme in the treatment of hidden penis.Methods The clinical data of 120 children with hidden penis treated in our hospital from January 2021 to June 2024 were retrospectively analyzed.The enrolled children were randomly divided into the study group(n=60)and the control group(n=60).The study group was treated with the Brisson technique combined with a precise measurement scheme,and the cutting of the penile skin was designed according to the data.The control group was treated with the traditional Devine technique.The surgical effects,penile lengths before and after surgery,and the incidence of postoperative complications of the children in the two groups were compared and analyzed.Results The effective rate of the study group reached 100%,which was significantly higher than that of the control group(93%,P<0.05).Six months after surgery,the penile length of the children in the study group was longer than that in the control group,and the difference was statistically significant(P<0.05).The incidence of surgical complications in the study group was 5%,which was significantly lower than that in the control group(17%,P<0.05).Conclusion Using the Brisson technique combined with a precise measurement scheme to treat hidden penis has a good effect,a high effective rate,and a low incidence of complications.
5.Real experience of the patients with implanted infusion port:a meta-synthesis of qualitative research
Qiongyao FENG ; Jinfeng JIANG ; Lihua YAN ; Yingchao GUO ; Qiu YANG
Modern Clinical Nursing 2025;24(4):71-80
Objective To systematically summarize the real experiences of the patients with totally implanted venous access ports(TIVAP)over the survival period of port-carrying,and provide references for formulation of the targeted health management programs.Methods A systematic search was conducted on databases of PubMed,Web of Science,Cochrane Library,CINAHL,Embase,PsycNET,China National Knowledge Infrastructure(CNKI),SinoMed,Wanfang Data base,and Vip for a qualitative study on the life experiences,needs,and feelings of patients with implanted infusion ports.The search period spanned from the inception of the databases to 3rd August,2024.Results A total of 14 studies were included,in 12 categories extracted from 38 research findings.Four synthesised results were further summarised,they were:impact on individual physical and mental health,impact on home life,challenges and needs in self-management and self-coping strategies of patients.Conclusion The implantation of TIVAP can produce both positive and negative experiences to the treatment as well as the life of patients.Healthcare professionals should be aware of the differences in emotion,cognition,need and personal coping strategy among the patients,hence to take effective measures to optimise the port-carrying experience of the patients,enhance the self-management enthusiasm and improve the quality of life of patients.
6.Real experience of the patients with implanted infusion port:a meta-synthesis of qualitative research
Qiongyao FENG ; Jinfeng JIANG ; Lihua YAN ; Yingchao GUO ; Qiu YANG
Modern Clinical Nursing 2025;24(4):71-80
Objective To systematically summarize the real experiences of the patients with totally implanted venous access ports(TIVAP)over the survival period of port-carrying,and provide references for formulation of the targeted health management programs.Methods A systematic search was conducted on databases of PubMed,Web of Science,Cochrane Library,CINAHL,Embase,PsycNET,China National Knowledge Infrastructure(CNKI),SinoMed,Wanfang Data base,and Vip for a qualitative study on the life experiences,needs,and feelings of patients with implanted infusion ports.The search period spanned from the inception of the databases to 3rd August,2024.Results A total of 14 studies were included,in 12 categories extracted from 38 research findings.Four synthesised results were further summarised,they were:impact on individual physical and mental health,impact on home life,challenges and needs in self-management and self-coping strategies of patients.Conclusion The implantation of TIVAP can produce both positive and negative experiences to the treatment as well as the life of patients.Healthcare professionals should be aware of the differences in emotion,cognition,need and personal coping strategy among the patients,hence to take effective measures to optimise the port-carrying experience of the patients,enhance the self-management enthusiasm and improve the quality of life of patients.
7.Preliminary Discussion on the Treatment of Hidden Penis with Brisson Technique Combined with Precise Measurement Scheme
Bin YANG ; Caixia LIU ; Na GUO ; Haoyang GAO ; Yi WANG ; Nan LI ; Haitao CHEN ; Yingchao LI
Journal of Clinical Surgery 2025;33(5):470-473
Objective To explore the clinical effect of using the Brisson technique combined with a precise measurement scheme in the treatment of hidden penis.Methods The clinical data of 120 children with hidden penis treated in our hospital from January 2021 to June 2024 were retrospectively analyzed.The enrolled children were randomly divided into the study group(n=60)and the control group(n=60).The study group was treated with the Brisson technique combined with a precise measurement scheme,and the cutting of the penile skin was designed according to the data.The control group was treated with the traditional Devine technique.The surgical effects,penile lengths before and after surgery,and the incidence of postoperative complications of the children in the two groups were compared and analyzed.Results The effective rate of the study group reached 100%,which was significantly higher than that of the control group(93%,P<0.05).Six months after surgery,the penile length of the children in the study group was longer than that in the control group,and the difference was statistically significant(P<0.05).The incidence of surgical complications in the study group was 5%,which was significantly lower than that in the control group(17%,P<0.05).Conclusion Using the Brisson technique combined with a precise measurement scheme to treat hidden penis has a good effect,a high effective rate,and a low incidence of complications.
8.Evaluation of colistin sulfate administration regimen based on PK/PD theory and Monte Carlo simulation
Yingchao MA ; Xia WU ; Yongjing WANG ; Jianjun GU ; Xiuling YANG
China Pharmacy 2025;36(4):459-463
OBJECTIVE To evaluate the therapeutic efficacy of 5 regimens of colistin sulfate for common Gram-negative bacilli infection based on pharmacokinetics(PK)/pharmacodynamics(PD)theory and Monte Carlo simulation.METHODS Minimal inhibitory concentration(MIC)data of colistin sulfate against Acinetobacter baumannii,Pseudomonas aeruginosa,Klebsiella pneumoniae,Escherichia coli and Enterobacter cloacae in 2023 were collected from the China Antimicrobial Resistance Surveillance System.Monte Carlo simulation was conducted with the ratio of the area under the concentration-time curve from 0 to 24 hours in the unbound state to the MIC(fAUC0-24 h/MIC)≥15 as the target value,the probabilities of target attainment(PTA)of 5 regimens of colistin sulfate to achieve the target ratio were obtained at different MIC;and the expected population PTA,specifically the cumulative fraction of response(CFR),for each regimen within a specific bacterial population was further calculated,to evaluate the therapeutic efficacy of the five colistin sulfate regimens.RESULTS When bacterial MIC≤0.5 μg/mL,PTA of all colistin sulfate regimens(500 000 IU,q12 h;500 000 IU,q8 h;750 000 IU,q12 h;750 000 IU,q8 h;1 000 000 IU,q12 h)were all more than 90%.When bacterial MIC=1 μg/mL,PTA for regimen(750 000 IU,q8 h)against A.baumannii,K.pneumoniae,P.aeruginosa,E.coli and E.cloacae,and for regimen(1 000 000 IU,q12 h)against the other four bacterial species(excluding P.aeruginosa)remained above 90%.When bacterial MIC≥2 μg/mL,PTA of 5 colistin sulfate regimens were all lower than 90%.For E.coli,the CFR of only colistin sulfate regimen(500 000 IU,q12 h)was less than 90%;for K.pneumoniae,the CFR of only colistin sulfate regimen(750 000 IU,q8 h and 1 000 000 IU,q12 h)was greater than 90%;for the other three bacteria,CFR of 5 regimens were all less than 90%.CONCLUSIONS When the MIC of Gram-negative bacteria is less than 0.5 μg/mL,colistin sulfate regimen with a routine dose can be selected for treatment.When MIC was 1 μg/mL,an increase in the dosing amount or frequency is required.The empirical treatment of the other four bacterial infections excluding E.coli requires the use of off-label doses.
9.Analysis of sequential chemotherapy efficacy in ovarian epithelial carcinoma, fallopian tube carcinoma and primary peritoneal carcinoma
Xiaoyan SHEN ; Xiaoping LI ; Yue WANG ; Yan WU ; Yi LI ; Yingchao YANG ; Lihui WEI ; Yuan FAN ; Ziqian TANG
Chinese Journal of Obstetrics and Gynecology 2024;59(5):383-390
Objective:To explore the sequential chemotherapy efficacy of different chemotherapeutic regimens in ovarian epithelial carcinoma, fallopian tube carcinoma, and primary peritoneal carcinoma.Methods:A retrospective analysis was conducted on clinical and pathological data of 100 patients with platinum-sensitive ovarian epithelial carcinoma, fallopian tube carcinoma, and primary peritoneal carcinoma treated at Peking University Peopel′s Hospital from January 1992 to January 2019. All patients underwent staging surgery or cytoreductive surgery followed by adjuvant chemotherapy. Based on different postoperative adjuvant chemotherapy regimens, patients were divided into the sequential chemotherapy group (70 cases) and the conventional chemotherapy group (30 cases). Clinical and pathological characteristics, chemotherapy efficacy, adverse reactions, and prognosis were compared between the two groups.Results:(1) Clinical and pathological characteristics: the age, tumor types (including ovarian epithelial carcinoma, fallopian tube carcinoma, and primary peritoneal carcinoma), pathological types, International Federation of Gynecology and Obstetrics (FIGO) stage, postoperative residual disease size, presence of neoadjuvant chemotherapy, and total number of chemotherapy cycles were compared between the sequential chemotherapy group and the conventional chemotherapy group. There were no statistically significant differences observed in these characteristics between the two groups (all P>0.05). (2) Chemotherapy efficacy: the median sum of complete response (CR)+partial response (PR) duration in the sequential chemotherapy group was 80.0 months (range: 39 to 369 months), whereas in the conventional chemotherapy group, it was 28.0 months (range: 13 to 52 months). A statistically significant difference was observed between the two groups ( Z=-7.82, P<0.001). (3) Chemotherapy adverse reactions: in the sequential chemotherapy group, 55 cases (79%, 55/70) experienced bone marrow suppression and 20 cases (29%, 20/70) had neurological symptoms. In the conventional chemotherapy group, these adverse reactions occurred in 11 cases (37%, 11/30) and 2 cases (7%, 2/30), respectively. Statistically significant differences were observed between the two groups for both bone marrow suppression and neurological symptoms (all P<0.05). For the other chemotherapy adverse reactions compared between the two groups, no statistically significant differences were observed (all P>0.05). (4) Prognosis: during the follow-up period, the recurrence rate in the sequential chemotherapy group was 73% (51/70) and in the conventional chemotherapy group was 100% (30/30). The median sum of recurrence-free interval was 70.5 months (range: 19 to 330 months) in the sequential chemotherapy group and 15.0 months (range: 6 to 40 months) in the conventional chemotherapy group. Statistically significant differences were observed between the two groups for both recurrence rate and median recurrence-free interval (all P<0.01).In the sequential chemotherapy group, the median progression-free survival (PFS) time was 84.0 months (range: 34 to 373 months), and the median overall survival (OS) time was 87.0 months (range: 45 to 377 months). In contrast, in the conventional chemotherapy group, the median PFS time was 30.5 months (range: 14 to 60 months), and the median OS time was 37.5 months (range: 18 to 67 months). Statistically significant differences were observed between the two groups for both PFS and OS (all P<0.001). In the sequential chemotherapy group, the 3-year, 5-year, and 10-year OS rates were 100% (70/70), 93% (65/70), and 21% (15/70), respectively. In contrast, in the conventional chemotherapy group, the OS rates were 50% (15/30) at 3 years, 3% (1/30) at 5 years, and 0 at 10 years, respectively. The two groups were compared respectively, and the differences were statistically significant (all P<0.05). Conclusions:Sequential chemotherapy significantly prolongs PFS and OS in patients with ovarian epithelial carcinoma, fallopian tube carcinoma, and primary peritoneal carcinoma. The efficacy is superior to that of the conventional chemotherapy, with manageable adverse reactions. The use of sequential chemotherapy as first-line treatment for patients with ovarian epithelial carcinoma, fallopian tube carcinoma, and primary peritoneal carcinoma is recommended.
10.Investigation on the influence of smoking on military pilot′s sleep quality
Yingchao ZHAI ; Junhua XING ; Shuying CUI ; Na SUN ; Ying LIU ; Jie YANG ; Li CUI
Chinese Journal of Aerospace Medicine 2024;35(2):125-127
Objective:To explore the effect of smoking on the sleep quality of military pilots.Methods:A questionnaire survey was conducted among military pilots who underwent a modified physical examination in Air Force Medical Center. The pilots were divided into smoking group and non-smoking group according to whether they smoked or not, and the Pittsburgh Sleep Quality Index (PSQI) was used to assess their sleep quality. The difference in sleep quality was compared between 2 groups.Results:A total of 665 questionnaires were issued, of which 627 were valid, with an effective rate of 94.29%. There were 291 pilots in smoking group and 336 in non-smoking group. The average sleep time of 627 military pilots was (7.58±0.70) h, and the average PSQI score was (2.93±0.09) points. The PSQI score of the smoking group was (3.28±0.14) points, and the PSQI score of the non-smoking group was (2.63±0.10) points, and the difference between 2 groups was significant ( Z=-3.17, P=0.002). Among the factors of the PSQI scale, there were significant differences in sleep onset time, sleep time, sleep efficiency, sleep disorder and daytime dysfunction between the smoking group and the non-smoking group ( Z=-5.85, -2.47, -1.98, -2.18, -1.98, P<0.001,=0.014, 0.049, 0.029, 0.049), and there was no statistically significance in sleep quality and hypnotic drugs intake ( Z=-1.65, -0.94, P=0.098, 0.347). Conclusions:Smoking can affect the sleep quality of military pilots, and it is necessary to actively carry out propaganda and education to persuade pilots away from smoking and maintain physical health.

Result Analysis
Print
Save
E-mail